Stem Cell Theranostics
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
1
Funding Rounds
$5.5m
Money raised
Overview
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** Le* | - | - | - |
Industries
Stem Cell Theranostics is active in the following industries: